These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3698464)

  • 21. Increased plasma norepinephrine accompanies persistent tachycardia after hydralazine.
    Lin MS; McNay JL; Shepherd AM; Musgrave GE; Keeton TK
    Hypertension; 1983; 5(2):257-63. PubMed ID: 6826216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hydralazine-induced renin release by indomethacin in the rat.
    Campbell WB; Graham RM; Jackson EK
    Arch Int Pharmacodyn Ther; 1980 Aug; 246(2):315-23. PubMed ID: 7002082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S; Liang CS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of indomethacin on the pressor responses to sustained isometric contraction in humans.
    Davy KP; Herbert WG; Williams JH
    J Appl Physiol (1985); 1993 Jul; 75(1):273-8. PubMed ID: 8376274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of aspirin and indomethacin on exercise-induced changes in blood pressure and limb blood flow in normal volunteers.
    Cowley AJ; Stainer K; Rowley JM; Wilcox RG
    Cardiovasc Res; 1985 Mar; 19(3):177-80. PubMed ID: 3986859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of atenolol with the systemic and regional hemodynamic effects of hydralazine in conscious renal hypertensive rabbits.
    Bolt GR; Saxena PR
    J Pharmacol Exp Ther; 1984 Jul; 230(1):205-13. PubMed ID: 6747826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of acute and chronic administration of idazoxan on blood pressure and plasma catecholamine concentrations of rats.
    Harland D; Brown MJ
    J Pharmacol Exp Ther; 1988 Apr; 245(1):265-73. PubMed ID: 3361445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of cyclo-oxygenase inhibitors on the cardiovascular effects of hydralazine in rats.
    Vidrio H; Garcia-Marquez F
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):131-41. PubMed ID: 3923959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oral labetalol on forearm and hepatic circulations in normotensive humans.
    Sweeney MO; Cinquegrani M; Liang CS
    J Lab Clin Med; 1987 May; 109(5):589-94. PubMed ID: 3572208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cyclooxygenase attenuates baroreceptor function and increases the pressor response to norepinephrine in man.
    Weisser B; Kayser G; Wagner S; Göbel BO; Vetter H; Düsing R
    Eur J Clin Pharmacol; 1992; 42(6):681-3. PubMed ID: 1623913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hydralazine on regional blood flow in conscious dogs.
    Chelly JE; Doursout MF; Begaud B; Tsao CC; Hartley CJ
    J Pharmacol Exp Ther; 1986 Aug; 238(2):665-9. PubMed ID: 3735136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of indomethacin on the circulatory and plasma noradrenaline responses to cold pressor testing in normal subjects.
    Davy KP; Williams JH; Herbert WG
    Clin Auton Res; 1993 Oct; 3(5):325-9. PubMed ID: 8124065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of the hypotensive action of prazosin.
    Oates HF; Graham RM; Stokes GS
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):41-8. PubMed ID: 901072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats.
    Smits JF; Struyker-Boudier HA
    J Pharmacol Exp Ther; 1985 Mar; 232(3):845-9. PubMed ID: 3973832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
    Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
    Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the direct vasodilator effect of hydralazine in the isolated rabbit renal artery.
    Khayyal M; Gross F; Kreye VA
    J Pharmacol Exp Ther; 1981 Feb; 216(2):390-4. PubMed ID: 7463355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro.
    Gorny D; Loufrani L; Kubis N; Lévy BI; Henrion D
    Microvasc Res; 2002 Jul; 64(1):127-34. PubMed ID: 12074639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in renal hemodynamics induced by Russell's viper venom: effects of indomethacin.
    Thamaree S; Sitprija V; Tongvongchai S; Chaiyabutr N
    Nephron; 1994; 67(2):209-13. PubMed ID: 8072611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.